About
Newsletter
Blog
CinCor Pharma
Pharmaceutical company acquired by AstraZeneca in 2023 for $1.8bn, with a focus on controlling hypertension, a common but life-threatening disease.
5 years
Future Forecast
1 year
Timeframe
3 months
6 months
1 year
2 years
5 years
10 years
15 years
Forecast
590
Volume
0%
Growth
peaked
Categories
company